M01.10.023 Bone Marrow Smear – Megakaryocyte

Learning Objectives

  • Identify the morphological appearance of megakaryocytes in a bone marrow smear.
  • Recognize the cytological features of erythroid and granulocytic precursors.
  • Understand the spatial arrangement of cells in a marrow aspirate.
  • Distinguish between polychromatophilic and orthochromatic erythroid stages.

Overview of Marrow Aspirate Cytology

In a bone marrow smear, cells are spread out to provide a detailed view of their internal structure. This view highlights the three main cell lines—megakaryocytic, erythroid, and granulocytic—which are produced simultaneously to maintain blood cell counts.


Characteristic Features

  • Megakaryocyte: Massive cells with lobulated, complex nuclei and abundant, granular, pinkish-purple cytoplasm. They are the giants of the bone marrow.
  • Erythroid Precursors: Identified by their perfectly round nuclei. Early stages have deep blue cytoplasm (high RNA), while later stages turn pink as hemoglobin accumulates.
  • Granulocytic Precursors: Cells in the “myeloid” line. They show oval or indented nuclei and may contain primary (purple) or secondary granules, depending on their maturity.

Cellular Dynamics

  • Platelet Shedding: Megakaryocytes extend long processes into marrow sinusoids, which then fragment to release platelets into the circulation.
  • Nuclear Extrusion: Once an erythroid precursor reaches the orthochromatic stage, it ejects its nucleus to become a reticulocyte.

Clinical Relevance: Hematologic Assessment

  • Immune Thrombocytopenia (ITP): In response to peripheral platelet destruction, the bone marrow often shows an increased number of megakaryocytes as it tries to compensate.
  • Pure Red Cell Aplasia: A rare condition where the marrow is almost entirely devoid of erythroid precursors while other cell lines (myeloid and megakaryocytic) remain normal.
  • Dyspoiesis: Pathologists look at these smears for “dysplastic” features, such as nuclear budding or ring sideroblasts, which are hallmark indicators of Myelodysplastic Syndromes (MDS).

Activity